Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Implications of the tumor immune microenvironment for staging and therapeutics
Janis M. Taube, Jérôme Galon, Lynette M. Sholl, et al.
Modern Pathology (2017) Vol. 31, Iss. 2, pp. 214-234
Open Access | Times Cited: 325

Showing 1-25 of 325 citing articles:

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jérôme Galon, Daniela Bruni
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 3, pp. 197-218
Closed Access | Times Cited: 2614
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni, Helen K. Angell, Jérôme Galon
Nature reviews. Cancer (2020) Vol. 20, Iss. 11, pp. 662-680
Closed Access | Times Cited: 1199
The updated landscape of tumor microenvironment and drug repurposing
Ming-Zhu Jin, Weilin Jin
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 887
The clinical role of the TME in solid cancer
Nicolás A. Giraldo, Rafael Sanchez‐Salas, J. David Peske, et al.
British Journal of Cancer (2018) Vol. 120, Iss. 1, pp. 45-53
Open Access | Times Cited: 549
Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade
Steve Lu, Julie E. Stein, David L. Rimm, et al.
JAMA Oncology (2019) Vol. 5, Iss. 8, pp. 1195-1195
Open Access | Times Cited: 516
Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
Zhilin Li, Xiaoqin Lai, Shiqin Fu, et al.
Advanced Science (2022) Vol. 9, Iss. 22
Open Access | Times Cited: 378
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation
Janis M. Taube, Güray Aktürk, Michael Angelo, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000155-e000155
Open Access | Times Cited: 207
Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC
Michael J. Grant, Roy S. Herbst, Sarah B. Goldberg
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 10, pp. 625-644
Closed Access | Times Cited: 204
Tumor microenvironment components: Allies of cancer progression
Pablo Igor Ribeiro Franco, Arthur Perillo Rodrigues, Liliana Borges de Menezes, et al.
Pathology - Research and Practice (2019) Vol. 216, Iss. 1, pp. 152729-152729
Closed Access | Times Cited: 200
Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination
M. Grapin, Corentin Richard, Emeric Limagne, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 175
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
Sneha Berry, Nicolás A. Giraldo, Benjamin Green, et al.
Science (2021) Vol. 372, Iss. 6547
Open Access | Times Cited: 165
Role of tumor microenvironment in cancer progression and therapeutic strategy
Qingjing Wang, Xueting Shao, Yuxuan Zhang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11149-11165
Open Access | Times Cited: 165
Tumor immune microenvironment lncRNAs
Eun-Gyeong Park, Sung-Jin Pyo, Youxi Cui, et al.
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 156
Microsatellite instability in Gastric Cancer: Between lights and shadows
Elisabetta Puliga, Simona Corso, Filippo Pietrantonio, et al.
Cancer Treatment Reviews (2021) Vol. 95, pp. 102175-102175
Open Access | Times Cited: 153
Exosomes and breast cancer drug resistance
Xingli Dong, Xupeng Bai, Jie Ni, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 148
Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions
Agnieszka Dominiak, Beata Chełstowska, Wioletta Olejarz, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1232-1232
Open Access | Times Cited: 141
Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma
Ming Yi, Anping Li, Linghui Zhou, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 6, pp. 1705-1719
Open Access | Times Cited: 112
Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy
Rangarirai Makuku, Neda Khalili, Sepideh Razi, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-15
Open Access | Times Cited: 104
Artificial intelligence for digital and computational pathology
Andrew H. Song, Guillaume Jaume, Drew F. K. Williamson, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 12, pp. 930-949
Closed Access | Times Cited: 82
Computational Approaches and Challenges in Spatial Transcriptomics
Shuangsang Fang, Bichao Chen, Yong Zhang, et al.
Genomics Proteomics & Bioinformatics (2022) Vol. 21, Iss. 1, pp. 24-47
Open Access | Times Cited: 71
The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer
André Steven, Barbara Seliger
Breast Care (2018) Vol. 13, Iss. 1, pp. 16-21
Open Access | Times Cited: 146
An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma
Yifei Dai, Weijie Qiang, Kequan Lin, et al.
Cancer Immunology Immunotherapy (2020) Vol. 70, Iss. 4, pp. 967-979
Open Access | Times Cited: 124
Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy
Dina Morein, Nofar Erlichman, Adit Ben‐Baruch
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 114
Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
Sijin Sun, Wei Guo, Zhen Wang, et al.
Cancer Medicine (2020) Vol. 9, Iss. 16, pp. 5960-5975
Open Access | Times Cited: 112
PD-L1 and Emerging Biomarkers in Immune Checkpoint Blockade Therapy
Tricia R. Cottrell, Janis M. Taube
The Cancer Journal (2018) Vol. 24, Iss. 1, pp. 41-46
Open Access | Times Cited: 110
Page 1 - Next Page

Scroll to top